Abbott Laboratories
ABTLast close · Oct 16, 2026104.88+0.20 (+0.19%)
Market cap$181.5B
Key indicators
Revenue45.1B+6.6% on a year earlier
30.6B
31.9B
34.6B
43.1B
43.7B
40.1B
42.0B
44.3B
45.1B
50.3B
54.7B
58.5B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 30.6B | 31.9B+4.3% | 34.6B+8.5% | 43.1B+24.5% | 43.7B+1.3% | 40.1B−8.1% | 42.0B+4.6% | 44.3B+5.7% | 45.1B+6.6% | 50.3B | 54.7B | 58.5B | |
| — | 4.3% | 8.5% | 24.5% | 1.3% | -8.1% | 4.6% | 5.7% | 6.6% | 13.5% | 8.7% | 7.0% | |
| $1.33 | $2.06+54.9% | $2.50+21.4% | $3.94+57.6% | $3.91−0.8% | $3.26−16.6% | $7.64+134.4% | $3.72−51.3% | $3.57−53.8% | $5.52 | $6.07 | $6.73 | |
| Profitability | ||||||||||||
| 11.9% | 14.2%+2.3 pt | 15.5%+1.3 pt | 19.6%+4.1 pt | 19.2%−0.4 pt | 16.2%−3.0 pt | 16.3%+0.1 pt | 18.2%+1.9 pt | 17.1%+0.2 pt | · | · | · | |
| 7.7% | 11.6%+3.8 pt | 13.0%+1.4 pt | 16.4%+3.4 pt | 15.9%−0.5 pt | 14.3%−1.6 pt | 31.9%+17.7 pt | 14.7%−17.2 pt | 13.9%−18.0 pt | · | · | · | |
| 7.8% | 11.9%+4.1 pt | 13.7%+1.9 pt | 19.8%+6.0 pt | 18.9%−0.9 pt | 14.8%−4.1 pt | 28.1%+13.3 pt | 12.5%−15.6 pt | — | · | · | · | |
| Cash | ||||||||||||
| 4.9B | 4.5B−8.3% | 5.7B+27.3% | 8.6B+51.1% | 7.8B−9.8% | 5.1B−35.2% | 6.4B+25.5% | 7.4B+16.4% | 7.4B+10.8% | · | · | · | |
| 16.0% | 14.1%−1.9 pt | 16.5%+2.4 pt | 20.1%+3.5 pt | 17.9%−2.2 pt | 12.6%−5.3 pt | 15.1%+2.5 pt | 16.7%+1.5 pt | 16.3%+0.6 pt | · | · | · | |
| 2.0B | 2.3B+15.0% | 2.6B+12.8% | 3.2B+25.1% | 3.3B+3.3% | 3.6B+7.5% | 3.8B+7.9% | 4.1B+7.3% | — | · | · | · | |
| Balance sheet | ||||||||||||
| 0.64x | 0.58x−0.06x | 0.57x−0.01x | 0.50x−0.07x | 0.46x−0.05x | 0.38x−0.08x | 0.30x−0.08x | 0.25x−0.05x | 0.65x+0.38x | · | · | · | |
| 1.77B | 1.78B+0.6% | 1.79B+0.3% | 1.79B+0.2% | 1.76B−1.4% | 1.75B−0.9% | 1.75B−0.1% | 1.75B+0.0% | 1.75B−0.0% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Mar 31, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.